FDA Approves Absurd Pill to Delay Diabetes

A monoclonal antibody injection has been approved for Type 1 diabetes. It only costs about $200K and comes with a risk of serious side effects.

STORY AT-A-GLANCE

• The U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv), made by drugmakers Sanofi and Provention Bio, for use in adults and children 8 years and older who have stage 2, Type 1 diabetes

• Tzield is a monoclonal antibody injection that neither treats nor prevents Type 1 diabetes

• The treatment is intended to delay the onset of…